Responding to an FDA warning letter (sent after previous interaction) with a marketing blog post takes some chuzpe. They even include "We stand by its accuracy, which the FDA has not questioned," as if FDA had assessed that for a device they haven't submitted for review.
Responding to an FDA warning letter (sent after previous interaction) with a marketing blog post takes some chuzpe. They even include "We stand by its accuracy, which the FDA has not questioned," as if FDA had assessed that for a device they haven't submitted for review.